Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: TMT
The Mission’s trading update indicates some early signs of increasing activity among clients in the technology, healthcare and property sectors. The overall trading background remains difficult, but the group has adapted its ways of working relatively smoothly, with the benefit of earlier moves to centralise IT and support functions. Group agencies have also been doing some COVID-19-specific work and community support, including a promising wearable proximity monitor from Pathfindr, developed within the group’s business incubator, fuse. Cost savings, including reduced salaries and non-payment of the FY19 final dividend, are helping preserve cash. Guidance and our forecasts remain withdrawn.
The Mission Group GrGroupEbiquity |
First green shoots |
COVID-19 update |
Media |
21 May 2020 |
Share price performance
Business description
Analyst
The Mission Group is a research client of Edison Investment Research Limited |
||||||||||||||||||||||||||||
The Mission’s trading update indicates some early signs of increasing activity among clients in the technology, healthcare and property sectors. The overall trading background remains difficult, but the group has adapted its ways of working relatively smoothly, with the benefit of earlier moves to centralise IT and support functions. Group agencies have also been doing some COVID-19-specific work and community support, including a promising wearable proximity monitor from Pathfindr, developed within the group’s business incubator, fuse. Cost savings, including reduced salaries and non-payment of the FY19 final dividend, are helping preserve cash. Guidance and our forecasts remain withdrawn.
Year end |
Revenue (£m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
12/17 |
68.6 |
9.1 |
9.0 |
1.7 |
6.3 |
3.0 |
12/18 |
77.6 |
9.2 |
8.5 |
2.1 |
6.6 |
3.7 |
12/19 |
81.0 |
10.2 |
9.0 |
0.8 |
6.3 |
1.4 |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Mission has had a development hub (fuse) for a while, bringing forward practical commercial projects that have emerged from client work. One of these, Pathfindr, is a system originally developed to locate items precisely within warehouses. This has now been repurposed as a wearable that warns if workers get closer than 2m to colleagues (easily done in a work situation) that is picking up press attention.
The marketing sector has been heavily affected by COVID-19 as clients have paused and reappraised their marketing strategies. The Advertising Association has published projections for the year that show UK advertising spend for FY20 will be down 16.7%, from a previous estimate of 5.2% growth. For FY21, it anticipates a 13.6% bounce back. Q220 is anticipated to be down 39.1%, with Q320 down 24.3%. However, the impact varies widely by advertising medium, sector and client. For some agencies and clients, the spur to creativity has boosted the impact of campaigns in a less crowded market.
|
|
Research: Healthcare
AFT Pharmaceuticals recently reported its FY20 results. Operating revenue grew by a strong 24.0% year-on-year to NZ$105.6m as there was at least double-digit growth across all regional segments and triple-digit growth in South-East Asia. Importantly, the company reported operating profit of NZ$21.2m (including a NZ$9.8m non-recurring gain), up from a reported NZ$6.1m the year before, and is guiding for operating profit of NZ$14–18m in FY21.